Legal Representation
Attorney
Emily M. Haas
USPTO Deadlines
Next Deadline
2120 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-04-29)
Due Date
April 29, 2031
Grace Period Ends
October 29, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
50 events| Date | Code | Type | Description |
|---|---|---|---|
| Apr 29, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Apr 29, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Apr 4, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Apr 4, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Mar 7, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Mar 7, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Mar 7, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Mar 4, 2025 | GNRT | O | NON-FINAL ACTION E-MAILED |
| Mar 4, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Mar 4, 2025 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN |
| Jan 19, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Jan 18, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Nov 4, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Nov 4, 2024 | IUAF | S | USE AMENDMENT FILED |
| Jun 13, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jun 4, 2024 | EXT3 | S | SOU EXTENSION 3 FILED |
| Jun 4, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Jun 4, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Apr 1, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Apr 1, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Apr 1, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Apr 1, 2024 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Apr 1, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Apr 1, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Dec 23, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Dec 21, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Dec 21, 2023 | EXT2 | S | SOU EXTENSION 2 FILED |
| Dec 21, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Apr 11, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Apr 7, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Apr 7, 2023 | EXT1 | S | SOU EXTENSION 1 FILED |
| Apr 7, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Dec 27, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Nov 1, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Nov 1, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Oct 12, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Sep 26, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sep 26, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Sep 26, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Sep 26, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Sep 26, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Sep 14, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sep 14, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sep 14, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Mar 16, 2022 | ALIE | A | ASSIGNED TO LIE |
| Mar 16, 2022 | GEAN | O | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Mar 16, 2022 | GEAP | F | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Mar 16, 2022 | CEPE | I | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED |
| Mar 16, 2022 | CPEA | R | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED |
| Mar 1, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
Detailed Classifications
Class 001
Chemical additives derived from microalgae, namely, cyanobacteria, for use in the manufacture of pharmaceuticals, cosmetics, veterinary preparations, and foodstuffs
First Use Anywhere:
Aug 29, 2023
First Use in Commerce:
Aug 29, 2023
Class 005
Vaccine preparations; adjuvants for use with vaccines; therapeutic antibodies for use as immunotherapeutic agents for targeting toxins, viruses and enterotoxic bacteria; biologic preparations for medical and therapeutic purposes, namely, the treatment and prevention of infectious diseases, deficiency diseases, hereditary diseases, physiological diseases, metabolic diseases, autoimmune diseases and gastrointestinal diseases; therapeutic agents for medical purposes, namely, biologic drugs targeted to treat specific diseases, namely, infectious diseases, deficiency diseases, hereditary diseases, physiological diseases, metabolic diseases, autoimmune diseases and gastrointestinal diseases
First Use Anywhere:
Aug 29, 2023
First Use in Commerce:
Aug 29, 2023
Additional Information
Design Mark
The mark consists of a circle made up of multiple molecules in various different sizes next to the words "LUMEN" and "BIOSCIENCE".
Classification
International Classes
001
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOSCIENCE"